Detalhe da pesquisa
1.
Evaluation of markers of immunity in different metastatic immune microenvironments suggests more suppression within breast to liver metastases in breast cancer.
Breast Cancer Res Treat
; 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643348
2.
Co-clinical FDG-PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple-negative breast cancer.
Eur J Nucl Med Mol Imaging
; 49(2): 550-562, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34328530
3.
Racial differences in no-show rates for screening mammography.
Cancer
; 127(11): 1857-1863, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792894
4.
Early Assessment Window for Predicting Breast Cancer Neoadjuvant Therapy using Biomarkers, Ultrasound, and Diffuse Optical Tomography.
Breast Cancer Res Treat
; 188(3): 615-630, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33970392
5.
Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer.
Breast Cancer Res Treat
; 189(1): 187-202, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34173924
6.
Predictors of Distant Metastases in Triple-Negative Breast Cancer Without Pathologic Complete Response After Neoadjuvant Chemotherapy.
J Natl Compr Canc Netw
; 18(3): 288-296, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32135512
7.
Assessing the effectiveness of the National Comprehensive Cancer Network genetic testing guidelines in identifying African American breast cancer patients with deleterious genetic mutations.
Breast Cancer Res Treat
; 178(1): 151-159, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31325073
8.
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial.
Lancet Oncol
; 19(6): 812-824, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29706375
9.
Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
Breast Cancer Res Treat
; 161(3): 491-499, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27915434
10.
Correction to: Coclinical FDGPET radiomic signature in predicting response to neoadjuvant chemotherapy in triplenegative breast cancer.
Eur J Nucl Med Mol Imaging
; 49(2): 788, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34550428
11.
Axillary Ultrasound Accurately Excludes Clinically Significant Lymph Node Disease in Patients With Early Stage Breast Cancer.
Ann Surg
; 264(6): 1098-1102, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26779976
12.
US breast cancer mortality trends in young women according to race.
Cancer
; 121(9): 1469-76, 2015 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25483625
13.
Time-trends in survival in young women with breast cancer in a SEER population-based study.
Breast Cancer Res Treat
; 138(1): 241-8, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23371505
14.
Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race.
Cancer Med
; 12(6): 7381-7388, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36404491
15.
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy.
J Immunother Cancer
; 11(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36918220
16.
Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins.
Cancer Res Commun
; 3(8): 1551-1563, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37587913
17.
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN).
NPJ Breast Cancer
; 9(1): 1, 2023 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36609389
18.
Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer.
Clin Cancer Res
; 29(9): 1719-1729, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36693175
19.
Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer.
Clin Cancer Res
; 29(16): 3092-3100, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37265453
20.
Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy.
Mod Pathol
; 25(3): 388-97, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22080062